ClariVest Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-14,870
| Closed | -$354K | – | 742 |
|
|
2016
Q4 | $354K | Sell |
14,870
-2,165
| -13% | -$51.5K | 0.01% | 436 |
|
|
2016
Q3 | $626K | Buy |
17,035
+3,515
| +26% | +$129K | 0.02% | 361 |
|
|
2016
Q2 | $301K | Buy |
13,520
+710
| +6% | +$15.8K | 0.01% | 424 |
|
|
2016
Q1 | $267K | Buy |
12,810
+1,740
| +16% | +$36.3K | 0.01% | 430 |
|
|
2015
Q4 | $335K | Buy |
11,070
+1,810
| +20% | +$54.8K | 0.01% | 394 |
|
|
2015
Q3 | $228K | Buy |
9,260
+60
| +0.7% | +$1.48K | 0.01% | 410 |
|
|
2015
Q2 | $295K | Buy |
+9,200
| New | +$295K | 0.01% | 374 |
|